Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jan;47(1):28-32.
doi: 10.1002/mus.23496. Epub 2012 Nov 21.

Clinical evolution of pure upper motor neuron disease/dysfunction (PUMMD)

Emanuele D'Amico  1 , Meredith Pasmantier, Yei-Won Lee, Louis Weimer, Hiroshi Mitsumoto
Affiliations

Clinical evolution of pure upper motor neuron disease/dysfunction (PUMMD)

Emanuele D'Amico et al. Muscle Nerve. 2013 Jan.

Erratum in

  • Muscle Nerve. 2014 Oct;50(4):619

Abstract

Introduction: PLS is defined as pure upper motor neuron disease/dysfunction (PUMND) beyond 48 months after symptom onset. We know little about its early stages, but such knowledge would help to identify the mechanisms underlying PLS and ALS and determine why PLS patients seem to be protected against lower MND (LMND).

Methods: We reviewed 622 MND cases during a 4-year period and identified 34 patients with PUMND (5.4%).

Results: Among 23 cases with follow-up data/electromyograms (EMGs; 2 had only 1 EMG), 13 (57%) remained classified as PUMND, and 8 (35%) developed LMND (mean, 51.4 months after onset). Of these 8, LMND developed in 3 after 48 months from symptom onset. Patients with PUMND and LMND were more functionally impaired (P = 0.02). Separately, we identified 5 patients with PUMND who developed LMND long after 48 months (range, 50-127 months).

Conclusions: PLS belongs to the ALS spectrum, and perhaps all cases eventually develop LMND.

PubMed Disclaimer

References

    1. Mitsumoto H, Chad D, Pioro EP. In: History, terminology and classification of ALS. Mitsumoto H, Chad D, Pioro EP, editors. Amyotroph Lateral Sc. Philadelphia: F.A. Davis Company; 1998. pp. 7–15.
    1. Swank RL, Putnam TJ. Amyotrophic lateral sclerosis and related conditions - A clinical analysis. Arch Neuro Psychiatr. 1943;49(2):151–177.
    1. Stark FM, Moersch FP. Primary Lateral Sclerosis - a Distinct Clinical Entity. J Nerv Ment Dis. 1945;102(4):332–337.
    1. Pringle CE, Hudson AJ, Munoz DG, Kiernan JA, Brown WF, Ebers GC. Primary lateral sclerosis. Clinical features, neuropathology and diagnostic criteria. Brain. 1992;115(Pt 2):495–520. - PubMed
    1. Le Forestier N, Maisonobe T, Piquard A, Rivaud S, Crevier-Buchman L, Salachas F, et al. Does primary lateral sclerosis exist? A study of 20 patients and a review of the literature. Brain. 2001;124:1989–1999. - PubMed

Publication types